Anti-Influenza Activity of an Ethyl Acetate Fraction of a Rhus verniciflua Ethanol Extract by Neuraminidase Inhibition
Open Access
- 29 October 2020
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2020, 1-15
Abstract
Antigenic mismatch can cause influenza vaccines to be ineffective, and influenza viruses resistant to antiviral drugs are rising. Thus, development of antiviral agents against these viruses is an immediate need. Rhus verniciflua (RVS) has long been used in herbal medicine and as a nutritional supplement. The effect of RVS and its components on influenza virus has not, however, been reported. We found that RVS treatment significantly reduced viral replication when evaluated with green fluorescent protein- (GFP-) tagged virus (influenza A virus, A/PR/8/34-GFP) in MadinDarby canine kidney (MDCK) cells. RVS showed significant inhibition of neuraminidase from A/PR/8/34. Subsequently, three fractions were prepared from an ethanolic crude extract of RVS. In vitro assays indicated that an ethyl acetate fraction (RVSE) was more potent than H2O and CHCl3 fractions. RVSE significantly suppressed influenza virus infection in MDCK cells via neuraminidase inhibition. Additionally, RVSE treatment inhibited expression of several virus proteins and decreased mortality of mice exposed to influenza A/PR/8/34 by 50 and reduced weight loss by 11.5. Active components in RVSE were isolated, and 5-deoxyluteolin (5) and sulfuretin (7) demonstrate the highest neuraminidase inhibitory activity against influenza A virus. RVS, RVSE, and their constituents may be useful for the development of anti-influenza agents.Keywords
Funding Information
- Ministry of Science, ICT and Future Planning (KSN2013230, NRF2020R1C1C1006749, NRF-2018R1D1A1B0704376013)
- Korea Institute of Oriental Medicine (KSN2013230, NRF2020R1C1C1006749, NRF-2018R1D1A1B0704376013)
- Ministry of Education (KSN2013230, NRF2020R1C1C1006749, NRF-2018R1D1A1B0704376013)
This publication has 45 references indexed in Scilit:
- The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus PolymerasePLOS ONE, 2013
- SwissDock, a protein-small molecule docking web service based on EADock DSSNucleic Acids Research, 2011
- Oseltamivir-resistant influenza viruses get by with a little help from permissive mutationsExpert Review of Anti-infective Therapy, 2011
- Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virusProceedings of the National Academy of Sciences, 2010
- Rhus verniciflua Stokes flavonoid extracts have anti-oxidant, anti-microbial and α-glucosidase inhibitory effectFood Chemistry, 2010
- The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunitNature, 2009
- Antiviral potentials of medicinal plantsVirus Research, 2008
- Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their UseAntimicrobial Agents and Chemotherapy, 2006
- Natural Products as Sources of New Drugs over the Period 1981−2002Journal of Natural Products, 2003
- LIGPLOT: a program to generate schematic diagrams of protein-ligand interactionsProtein Engineering, Design and Selection, 1995